Your session is about to expire
← Back to Search
Atezolizumab for Non-Small Cell Lung Cancer
Study Summary
This trial is testing a new combination cancer treatment that includes the drugs carboplatin, pemetrexed, atezolizumab, and bevacizumab. The treatment will be given every three weeks for up to four cycles, and patients who don't respond to the treatment after four cycles will be able to continue receiving the treatment until their cancer progresses or they experience intolerable side effects.
- Non-Small Cell Lung Cancer
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2019 Phase 3 trial • 1225 Patients • NCT02008227Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
How many participants have joined this experiment thus far?
"This medical trial has ceased recruitment as of February 16th 2022. At present, there are 1,371 clinical trials for carcinoma non-small cell lung and 1,284 studies with Atezolizumab actively seeking participants."
What afflictions does Atezolizumab typically treat?
"Atezolizumab has been used to successfully treat endometrial cancer, melanoma and recurrent ovarian epithelial cancers that remain sensitive to platinum-based chemotherapy."
Are there any vacancies for willing participants in this experiment?
"Currently, this clinical trial is not enrolling. Initially posted on November 15th 2018 and last edited on February 16th 2022, the study has been placed in a dormant state. If you are looking for other trials to participate in, there are 1,371 studies actively recruiting those with carcinoma non-small cell lung cancer and 1,284 studies seeking patients for atezolizumab treatment."
How many medical centers in this state are administering the trial?
"Individuals interested in participating can register at University of Virginia Health System (Charlottesville, VA), ProHealth Care (Waukesha, WI) and the University of Wisconsin (Madison, IN). Additionally there are 4 other locations."
What other research projects have been conducted with Atezolizumab?
"As of now, 1284 clinical studies are being conducted on Atezolizumab with 33% in Phase 3. While a majority of these trials occur in Shanghai, there is an expansive network of 72492 sites hosting research involving the drug."
What potential risks of injury are associated with Atezolizumab use?
"Based on the evidence currently available, our team at Power assessed Atezolizumab's safety to be a 2. As this is only Phase 2 of clinical trials, there has been data indicating its security but none in regards to efficacy yet."
Share this study with friends
Copy Link
Messenger